Welcome to LookChem.com Sign In|Join Free
  • or
Shanghai PengMo Biotechnology Co.,LtdTigecycline//file1.lookchem.com/cas/reactions/2021/07/08/8379453.png
qq

Communicate with Supplier:

Ms. pamela
Ms. pamela: What can I do for you?

Tigecycline CAS NO.220620-09-7

Min.Order Quantity:
1 Kilogram
Purity:
99%
Port:
Shanghai
Payment Terms:
T/T,MoneyGram,Other

Add to Inquiry Cart

Product Details

Keywords

  • Tigecycline manufacture
  • Tigecycline buy
  • Tigecycline high quality

Quick Details

  • ProName: Tigecycline
  • CasNo: 220620-09-7
  • Appearance: Orange crystalline powder
  • Application: glycylcycline antibiotic
  • DeliveryTime: within 1-7 days after your payment
  • PackAge: aluminum foil bag or customized
  • Port: Shanghai
  • ProductionCapacity: 100 Kilogram/Month
  • Purity: 99%
  • Storage: cool.sealed place
  • Transportation: by courier or as your request
  • LimitNum: 1 Kilogram

Superiority

we could give you:
1. best quality in your requirement
2. competitive price in china market
3. mature technical support
4. professional logistic support

Details

name: tigecycline
protein binding:71-89%
metabolism:not metabolised
half-life:42.4 hours
excretion:59% biliary, 33% renal
cas number:220620-09-7
chemspider:10482314
unii:70je2n95kr
kegg:d01079
formula:c29h39n5o8
mol. mass:585.65 g/mol
synonyms:n-[(5ar,6as,7s,9z,10as)-9-(amino-hydroxy-methylidene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5h-tetracen-2-yl]-2-(tert-butylamino)acetamide
iupac:n-[(5ar,6as,7s,9z,10as)-9-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5,5a,6,6a,7,8,9,10,10a,11-decahydrotetracen-2-yl]-2-(tert-butylamino)acetamide

product information:
tigecycline is the first drug in the glycylcycline class of antibiotics. although it is structurally related to minocycline, alterations to the molecule resulted in its expanded spectrum of activity and decreased susceptibility to the development of resistance when compared with other tetracycline antibiotics. tigecycline has a broad spectrum of activity, including activity against drug-resistant gram-positive organisms. randomized trials have shown tigecycline to be efficacious for the treatment of complicated intraabdominal infections and complicated skin and skin structure infections. the dose of tigecycline is 50 mg intravenously every 12 hours after a 100-mg loading dose. nausea, vomiting, and diarrhea were the most common adverse events reported with tigecycline therapy and may result in discontinuation of therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)